send link to app

Clinical6 Mobile


4.2 ( 7952 ratings )
Medicina
Desarrollador Parallel 6, Inc.
Libre

Clinical6 Mobile for Medidatas Symposium 2016, is a version of the leading Clinical Trial Patient enrollment and engagement solution. The app is available only to participants in the Mock Trial. Registration Credentials are prepopulated to facilitate login.

Users please note: Continued use of GPS running in the background can dramatically decrease battery life.

FAST, COMPLIANT & SECURE
Clinical6 offers the fastest path to patient engagement and provides convenient access to the features and functionality that clinicians rely on most in Clinical Trials, even when offline!

EASILY DIGESTIBLE INFORMATION & ACTIONABLE DATA
The same authoritative content, but more concise and easier to access: simply tap thru to the exact level of detail you require. Toggle multiple views within the same interface to apply the precise clinical lens - Trial info, medication schedules, surveys, eCOA, and more. 

MEDICATION CYCLES
Easily identify pills using the medication cycle and trial tracking features to understand dosages. Instantly know where you are in the trial, check medication adherence, take a quick survey, and see future appointments.

POWERFUL CLINICAL TOOLS 
Evidence-supported clinical algorithms to quickly identify medication compliance, visit compliance, or adverse reactions
Medication interaction report – gain immediate feedback on interactions as Patients taking their drugs, leading to an easy-to-scan synoptic description of interactions.
Take trial-specific surveys, make event reports, tap through short and long schedule views

FEWER TAPS, QUICKER ANSWERS 
Built by Patients for Patients, real time interactions from anywhere in the world was the operating principle that guided every decision around the app’s navigation, flow and content structure. Each major feature is one-tap away, and all extraneous steps have been removed or optimized to complement a Patient’s busy life. 

QUESTIONS/FEEDBACK
Additional questions or problems accessing the application? Please contact [email protected].